Rechallenge of patients previously treated with adjuvant anthracyclines using pegylated liposomal doxorubicin (PLD) with cyclophosphamide (C) as first-line chemotherapy for metastatic breast cancer (MBC)

被引：0
|
作者：
Trudeau, M. [1 ]
Clemons, M. [1 ]
Provencher, L. [2 ]
Panasci, L. [3 ]
Yelle, L. [4 ]
Rayson, D. [5 ]
Latreille, J. [6 ]
Vandenberg, T.
Pouliot, J. [7 ]
机构：
[1] Sunnybrook Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada
[2] Hop St Sacrement, Quebec City, PQ, Canada
[3] McGill Univ, Jewish Gen Hosp, Montreal, PQ H3T 1E2, Canada
[4] Univ Montreal, Notre Dame Hosp, Montreal, PQ H3C 3J7, Canada
[5] QE II Hlth Sci Ctr, Halifax, NS, Canada
[6] Hosp Charles Lemoyne, Longueuil, PQ, Canada
[7] Schering Canada Inc, Pointe Claire, PQ, Canada
来源：
BREAST | 2007年 / 16卷
关键词：
D O I：
10.1016/S0960-9776(07)70202-3
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S54 / S54
页数：1
相关论文
共 50 条
  • [1] Phase II Multicenter Trial of Anthracycline Rechallenge With Pegylated Liposomal Doxorubicin Plus Cyclophosphamide for First-Line Therapy of Metastatic Breast Cancer Previously Treated With Adjuvant Anthracyclines
    Trudeau, Maureen E.
    Clemons, Mark J.
    Provencher, Louise
    Panasci, Lawrence
    Yelle, Louise
    Rayson, Daniel
    Latreille, Jean
    Vandenberg, Ted
    Goel, Rakesh
    Zibdawi, Labib
    Rahim, Yasmin
    Pouliot, Jean-Francois
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (35) : 5906 - 5910
  • [2] Pegylated Liposomal Doxorubicin (Caelyx®) and Oral Vinorelbine in First-Line Metastatic Breast Cancer Patients Previously Treated with Anthracyclines
    Livi, L.
    Meattini, I.
    Scotti, V.
    Cardillo, C. De Luca
    Galardi, A.
    Iermano, C.
    Sanchez, L.
    Nori, J.
    Mangoni, M.
    Franzese, C.
    Orzalesi, L.
    Bertocci, S.
    Agresti, B.
    Masoni, T.
    Bianchi, S.
    Cataliotti, L.
    Biti, G.
    [J]. JOURNAL OF CHEMOTHERAPY, 2011, 23 (03) : 158 - 162
  • [3] Pilot study with pegylated liposomal doxorubicin (PLD) and docetaxel as first-line treatment in patients with metastatic breast cancer (MBC)
    Mel, J. R., Sr.
    Ramos, M.
    Cueva, J.
    Castellanos, J.
    Almanza, C.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [4] PEGYLATED LIPOSOMAL DOXORUBICIN (PLD) AND WEEKLY PACLITAXEL (T) AS FIRST-LINE TREATMENT IN METASTATIC BREAST CANCER (MBC)
    Badalamenti, Giuseppe
    Valerio, Maria Rosaria
    Rinaldi, Gaetana
    Arcara, Carlo
    Cicero, Giuseppe
    Vizzini, Laura
    Travagliato, Maria Grazia
    Intrivici, Chiara
    Russo, Antonio
    Gulotta, Gaspare
    Gebbia, Nicola
    Fulfaro, Fabio
    [J]. ANNALS OF ONCOLOGY, 2004, 15 : 24 - 24
  • [5] Efficacy of capecitabine (C)-based therapy in patients with first-line metastatic breast cancer (MBC) previously treated with adjuvant anthracyclines and taxanes
    Siedentopf, F.
    Schoenegg, W.
    Kaufmann, M.
    Debled, M.
    Robert, N. J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [6] Liposomal doxorubicin (Myocet (R)) with cyclophosphamide for first-line therapy of metastatic breast cancer in patient previously treated with anthracyclines in the adjuwant setting
    Kustra, Magdalena
    Nowara, Elzbieta
    [J]. ONCOLOGY IN CLINICAL PRACTICE, 2010, 6 : A25 - A27
  • [7] Pegylated liposomal doxorubicin (PILD) plus cyclophosphamide as 1st-line therapy for metastatic breast cancer in patients previously treated with anthracyclines
    Trudeau, M.
    Provencher, L.
    Panasci, L.
    Yelle, L.
    Latreille, J.
    Varidenberg, T. A.
    Rayson, D.
    Rodgers, A.
    Pouliot, J. F.
    [J]. EJC SUPPLEMENTS, 2005, 3 (02): : 130 - 131
  • [8] Weekly paclitaxel and pegylated liposomal doxorubicin (PLD) as first-line therapy in metastatic breast cancer
    Valerio, M. R.
    Fulfaro, F.
    Cicero, G.
    Rinaldi, G.
    Maiorana, O.
    Spinnato, F.
    Intrivici, C.
    Crosta, A.
    Scibilia, C.
    Pizzo, T.
    Vanella, P.
    Gebbia, N.
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : VII147 - VII147
  • [9] Myotax: A phase II trial of docetaxel plus non-pegylated liposomal doxorubicin as first-line therapy of metastatic breast cancer previously treated with adjuvant anthracyclines
    Curtit, E.
    Nouyrigat, P.
    Dohollou, N.
    Levy, E.
    Lortholary, A.
    Gligorov, J.
    Facchini, T.
    Jaubert, D.
    Maille, N.
    Pivot, X.
    Grange, V.
    Cals, L.
    [J]. EUROPEAN JOURNAL OF CANCER, 2011, 47 (16) : 2396 - 2402
  • [10] Weekly paclitaxel (T) and pegylated liposomal doxorubicin (PLD) as first line treatment in metastatic breast cancer (MBC) patients.
    Fulfaro, F
    Valerio, MR
    Badalamenti, G
    Arcara, C
    Cicero, G
    Intrivici, C
    Crosta, A
    Sciortino, C
    Russo, A
    Gebbia, N
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 53S - 53S
12345